Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 4.08
(-1.69%)
CNY 4.08
(-1.69%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 379.62 Million CNY | -21.8% |
| 2022 | 485.44 Million CNY | -7.24% |
| 2021 | 523.32 Million CNY | -7.78% |
| 2020 | 567.5 Million CNY | 78.23% |
| 2019 | 318.41 Million CNY | -66.81% |
| 2018 | 959.32 Million CNY | 94.02% |
| 2017 | 494.44 Million CNY | -0.96% |
| 2016 | 499.22 Million CNY | 17706.52% |
| 2015 | 2.8 Million CNY | 100.96% |
| 2014 | -292.33 Million CNY | -215.17% |
| 2013 | 253.83 Million CNY | 132.72% |
| 2012 | 109.07 Million CNY | 28.24% |
| 2011 | 85.05 Million CNY | -23.16% |
| 2010 | 110.68 Million CNY | 55.03% |
| 2009 | 71.39 Million CNY | -25.42% |
| 2008 | 95.73 Million CNY | -44.42% |
| 2007 | 172.23 Million CNY | -23.56% |
| 2006 | 225.32 Million CNY | 6.09% |
| 2005 | 212.39 Million CNY | 266.28% |
| 2004 | 57.98 Million CNY | -49.76% |
| 2003 | 115.42 Million CNY | 1029.43% |
| 2002 | 10.21 Million CNY | -80.91% |
| 2001 | 53.54 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 308.07 Million CNY | 44.3% |
| 2024 Q3 | -48.25 Million CNY | -115.66% |
| 2024 Q1 | 213.49 Million CNY | -43.76% |
| 2023 Q1 | 497.32 Million CNY | 2.45% |
| 2023 Q3 | 294.16 Million CNY | -33.77% |
| 2023 Q4 | 379.62 Million CNY | 29.05% |
| 2023 FY | 379.62 Million CNY | -21.8% |
| 2023 Q2 | 444.16 Million CNY | -10.69% |
| 2022 Q2 | 587.51 Million CNY | 4.79% |
| 2022 Q3 | 460.25 Million CNY | -21.66% |
| 2022 Q4 | 485.44 Million CNY | 5.47% |
| 2022 FY | 485.44 Million CNY | -7.24% |
| 2022 Q1 | 560.68 Million CNY | 7.14% |
| 2021 Q4 | 523.32 Million CNY | 23.14% |
| 2021 Q3 | 424.97 Million CNY | 11.65% |
| 2021 FY | 523.32 Million CNY | -7.78% |
| 2021 Q2 | 380.63 Million CNY | 127.84% |
| 2021 Q1 | 167.06 Million CNY | -70.56% |
| 2020 FY | 567.5 Million CNY | 78.23% |
| 2020 Q1 | 300.64 Million CNY | -5.58% |
| 2020 Q2 | 298.95 Million CNY | -0.56% |
| 2020 Q3 | 605.71 Million CNY | 102.61% |
| 2020 Q4 | 567.5 Million CNY | -6.31% |
| 2019 Q3 | 543.16 Million CNY | 12.73% |
| 2019 Q2 | 481.82 Million CNY | -22.99% |
| 2019 Q1 | 625.68 Million CNY | -34.78% |
| 2019 FY | 318.41 Million CNY | -66.81% |
| 2019 Q4 | 318.41 Million CNY | -41.38% |
| 2018 Q3 | 922.29 Million CNY | 0.19% |
| 2018 FY | 959.32 Million CNY | 94.02% |
| 2018 Q4 | 959.32 Million CNY | 4.01% |
| 2018 Q2 | 920.56 Million CNY | 11.56% |
| 2018 Q1 | 825.15 Million CNY | 66.89% |
| 2017 FY | 494.44 Million CNY | -0.96% |
| 2017 Q1 | 581.85 Million CNY | 16.55% |
| 2017 Q2 | 352.78 Million CNY | -39.37% |
| 2017 Q3 | 458.24 Million CNY | 29.89% |
| 2017 Q4 | 494.44 Million CNY | 7.9% |
| 2016 Q3 | 209.74 Million CNY | 5.84% |
| 2016 FY | 499.22 Million CNY | 17706.52% |
| 2016 Q1 | 316.45 Million CNY | 11187.56% |
| 2016 Q2 | 198.16 Million CNY | -37.38% |
| 2016 Q4 | 499.22 Million CNY | 138.01% |
| 2015 Q4 | 2.8 Million CNY | -99.22% |
| 2015 Q2 | 340.83 Million CNY | 1034.75% |
| 2015 Q1 | -36.46 Million CNY | 87.53% |
| 2015 FY | 2.8 Million CNY | 100.96% |
| 2015 Q3 | 360.16 Million CNY | 5.67% |
| 2014 FY | -292.33 Million CNY | -215.17% |
| 2014 Q3 | -531.3 Million CNY | 36.03% |
| 2014 Q4 | -292.33 Million CNY | 44.98% |
| 2014 Q2 | -830.58 Million CNY | -12.89% |
| 2014 Q1 | -735.73 Million CNY | -389.85% |
| 2013 FY | 253.83 Million CNY | 132.72% |
| 2013 Q4 | 253.83 Million CNY | 18.88% |
| 2013 Q1 | 102.28 Million CNY | -6.23% |
| 2013 Q2 | -347.36 Million CNY | -439.61% |
| 2013 Q3 | 213.52 Million CNY | 161.47% |
| 2012 Q4 | 109.07 Million CNY | 274.43% |
| 2012 Q2 | -144.59 Million CNY | -311.22% |
| 2012 Q1 | 68.45 Million CNY | -19.51% |
| 2012 FY | 109.07 Million CNY | 28.24% |
| 2012 Q3 | -62.53 Million CNY | 56.76% |
| 2011 FY | 85.05 Million CNY | -23.16% |
| 2011 Q4 | 85.05 Million CNY | -37.33% |
| 2011 Q3 | 135.7 Million CNY | 30.64% |
| 2011 Q2 | 103.88 Million CNY | -37.61% |
| 2011 Q1 | 166.48 Million CNY | 50.42% |
| 2010 FY | 110.68 Million CNY | 55.03% |
| 2010 Q1 | 134.02 Million CNY | 87.73% |
| 2010 Q2 | 186.79 Million CNY | 39.37% |
| 2010 Q3 | 144.71 Million CNY | -22.52% |
| 2010 Q4 | 110.68 Million CNY | -23.52% |
| 2009 Q2 | 108.57 Million CNY | -30.64% |
| 2009 Q4 | 71.39 Million CNY | -38.53% |
| 2009 Q3 | 116.14 Million CNY | 6.98% |
| 2009 Q1 | 156.53 Million CNY | 63.51% |
| 2009 FY | 71.39 Million CNY | -25.42% |
| 2008 Q4 | 95.73 Million CNY | -51.16% |
| 2008 FY | 95.73 Million CNY | -44.42% |
| 2008 Q1 | 220.04 Million CNY | 27.76% |
| 2008 Q2 | 224.4 Million CNY | 1.98% |
| 2008 Q3 | 196.02 Million CNY | -12.65% |
| 2007 Q3 | 217.24 Million CNY | -1.79% |
| 2007 Q1 | 290.49 Million CNY | 28.92% |
| 2007 FY | 172.23 Million CNY | -23.56% |
| 2007 Q2 | 221.19 Million CNY | -23.86% |
| 2007 Q4 | 172.23 Million CNY | -20.72% |
| 2006 Q2 | 228.14 Million CNY | -13.45% |
| 2006 Q1 | 263.59 Million CNY | 24.11% |
| 2006 Q4 | 225.32 Million CNY | -19.82% |
| 2006 FY | 225.32 Million CNY | 6.09% |
| 2006 Q3 | 281.03 Million CNY | 23.18% |
| 2005 Q3 | 200.92 Million CNY | 17.86% |
| 2005 Q4 | 212.39 Million CNY | 5.71% |
| 2005 Q1 | 116.19 Million CNY | 100.37% |
| 2005 FY | 212.39 Million CNY | 266.28% |
| 2005 Q2 | 170.46 Million CNY | 46.71% |
| 2004 Q4 | 57.98 Million CNY | -30.08% |
| 2004 Q2 | 39.39 Million CNY | 166.13% |
| 2004 FY | 57.98 Million CNY | -49.76% |
| 2004 Q1 | -59.57 Million CNY | -151.62% |
| 2004 Q3 | 82.93 Million CNY | 110.51% |
| 2003 Q4 | 115.42 Million CNY | 0.0% |
| 2003 FY | 115.42 Million CNY | 1029.43% |
| 2002 FY | 10.21 Million CNY | -80.91% |
| 2001 FY | 53.54 Million CNY | 0.0% |